Revance Therapeutics
RVNC
$3.32
Share price
-22.61%
Change (1 day)
-90.71%
Change (1 year)
Categories
EPS for Revance Therapeutics (RVNC)
EPS in 2023 (TTM): -$4.53
According to Revance Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.53. In 2022 the company made an earnings per share (EPS) of -$4.81 a decrease over its 2021 EPS that were of -$4.18.
EPS history for Revance Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.53 | -5.82% |
| 2022 | -$4.81 | 15.07% |
| 2021 | -$4.18 | -13.81% |
| 2020 | -$4.85 | 32.51% |
| 2019 | -$3.66 | -7.11% |
| 2018 | -$3.94 | -1.25% |
| 2017 | -$3.99 | 25.47% |
| 2016 | -$3.18 | 6% |
| 2015 | -$3.00 | -21.47% |
| 2014 | -$3.82 | 0.04% |
| 2013 | -$3.82 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -410.93% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | -507.51% | 🇺🇸 USA |
 MediciNova MNOV | -$0.25 | -94.48% | 🇺🇸 USA |